Powered by

2nd Annual Next Gen Immuno-Oncology Congress (Philadelphia, PA, United States - September 19-20, 2019) - ResearchAndMarkets.com

Aug 29, 2019 - Business Wire

The "2nd Annual Next Gen Immuno-Oncology Congress" conference has been added to ResearchAndMarkets.com's offering.

The current revolution in immuno-oncology is being driven by Antibody Drug Conjugates, Immune Checkpoint Inhibitors, Bispecific Antibodies, and Cell Therapies.

Clinical trials have shown that cancer patients can tolerate this immune-based treatment more effectively than conventional treatments like chemotherapy and radiotherapy. It's clearly one of the hottest fields of ...